Fumitaka Morito
About
In The Last Decade
Fumitaka Morito
36 papers receiving 609 citations
Peers
Comparison fields: 5 of 75
- Immunology 270
- Molecular Biology 168
- Rheumatology 126
- Oncology 72
- Immunology and Allergy 68
Countries citing papers authored by Fumitaka Morito
This map shows the geographic impact of Fumitaka Morito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumitaka Morito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumitaka Morito more than expected).
Fields of papers citing papers by Fumitaka Morito
This network shows the impact of papers produced by Fumitaka Morito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumitaka Morito. The network helps show where Fumitaka Morito may publish in the future.
Co-authorship network of co-authors of Fumitaka Morito
This figure shows the co-authorship network connecting the top 25 collaborators of Fumitaka Morito. A scholar is included among the top collaborators of Fumitaka Morito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumitaka Morito. Fumitaka Morito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 23 | |
| 2 | 22 | |
| 3 | 14 | |
| 4 | 7 | |
| 5 | 43 | |
| 6 | 31 | |
| 7 | 32 | |
| 8 | 49 | |
| 9 | 46 | |
| 10 | 69 | |
| 11 | 9 | |
| 12 | 11 | |
| 13 | 3 | |
| 14 | 13 | |
| 15 | 21 | |
| 16 | 13 | |
| 17 | 13 | |
| 18 | 27 | |
| 19 | 31 | |
| 20 | [Plasma fibronectin levels in patients with vulgar psoriasis]. | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.